A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Phase 1/2 Completed
23 enrolled
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery
Phase 1/2 Completed
51 enrolled 20 charts
ConsortiumIO
Phase 1/2 Completed
56 enrolled 11 charts
Study of ESG401 in Adults With Solid Tumors
Phase 1/2 Completed
156 enrolled
GLIMMER-01
Phase 1/2 Completed
69 enrolled 13 charts
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Phase 1/2 Completed
145 enrolled 47 charts
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
Phase 1/2 Completed
316 enrolled
TALENT
Phase 1/2 Completed
65 enrolled
Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery
Phase 1/2 Completed
31 enrolled 20 charts
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Phase 1/2 Completed
84 enrolled
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies
Phase 1/2 Completed
40 enrolled 11 charts
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
Phase 1/2 Completed
95 enrolled 26 charts
Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab
Phase 1/2 Completed
71 enrolled
Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT)
Phase 1/2 Completed
41 enrolled 8 charts
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
Phase 1/2 Completed
41 enrolled
Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Phase 1/2 Completed
78 enrolled 15 charts
Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer
Phase 1/2 Completed
49 enrolled
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Phase 1/2 Completed
203 enrolled
A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)
Phase 1/2 Completed
116 enrolled
GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study
Phase 1/2 Completed
58 enrolled
IPLUS
Phase 1/2 Completed
35 enrolled
Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients
Phase 1/2 Completed
27 enrolled
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Phase 1/2 Completed
49 enrolled
PIVOT-02
Phase 1/2 Completed
557 enrolled 22 charts
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Phase 1/2 Completed
52 enrolled 25 charts
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
Phase 1/2 Completed
444 enrolled 19 charts
A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects
Phase 1/2 Completed
11 enrolled
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
Phase 1/2 Completed
117 enrolled 18 charts
A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer
Phase 1/2 Completed
34 enrolled
Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP
Phase 1/2 Completed
22 enrolled 11 charts
REPEAT
Phase 1/2 Completed
47 enrolled
A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer
Phase 1/2 Completed
46 enrolled
Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor
Phase 1/2 Completed
59 enrolled 16 charts
Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer
Phase 1/2 Completed
63 enrolled
Study of Adjuvant Radiochemotherapy for Gastric Cancer
Phase 1/2 Completed
65 enrolled
Dovitinib Plus Docetaxel in Gastric Cancer
Phase 1/2 Completed
14 enrolled
A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer
Phase 1/2 Completed
28 enrolled
Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients
Phase 1/2 Completed
98 enrolled 8 charts
A Trial of RAD001/Capecitabine in Refractory Gastric Cancer
Phase 1/2 Completed
59 enrolled
The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer
Phase 1/2 Completed
19 enrolled
GASTANA
Phase 1/2 Completed
16 enrolled
AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer
Phase 1/2 Completed
130 enrolled
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
Phase 1/2 Completed
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
Phase 1/2 Completed
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
Phase 1/2 Completed
CORGI
Phase 1/2 Completed
106 enrolled
Image-guided Minimally Invasive Robotic Surgery Using Preoperative CT Scan for Gastric Cancer Patients
Phase 1/2 Completed
12 enrolled
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer
Phase 1/2 Completed
14 enrolled
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer
Phase 1/2 Completed
14 enrolled